Cite
Treatment with hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone combined with cytarabine and methotrexate results in poor mobilization of peripheral blood stem cells in patients with mantle cell lymphoma.
MLA
Hill, Brian T., et al. “Treatment with Hyperfractionated Cyclophosphamide, Vincristine, Doxorubicin, and Dexamethasone Combined with Cytarabine and Methotrexate Results in Poor Mobilization of Peripheral Blood Stem Cells in Patients with Mantle Cell Lymphoma.” Leukemia & Lymphoma, vol. 52, no. 6, June 2011, pp. 986–93. EBSCOhost, https://doi.org/10.3109/10428194.2010.551154.
APA
Hill, B. T., Rybicki, L., Smith, S., Dean, R., Kalaycio, M., Pohlman, B., Sweetenham, J., Tench, S., Sobecks, R., Andresen, S., Copelan, E., & Bolwell, B. J. (2011). Treatment with hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone combined with cytarabine and methotrexate results in poor mobilization of peripheral blood stem cells in patients with mantle cell lymphoma. Leukemia & Lymphoma, 52(6), 986–993. https://doi.org/10.3109/10428194.2010.551154
Chicago
Hill, Brian T., Lisa Rybicki, Stephen Smith, Robert Dean, Matt Kalaycio, Brad Pohlman, John Sweetenham, et al. 2011. “Treatment with Hyperfractionated Cyclophosphamide, Vincristine, Doxorubicin, and Dexamethasone Combined with Cytarabine and Methotrexate Results in Poor Mobilization of Peripheral Blood Stem Cells in Patients with Mantle Cell Lymphoma.” Leukemia & Lymphoma 52 (6): 986–93. doi:10.3109/10428194.2010.551154.